Medical device affairs outsourcing market seen reaching $7.65 billion by 2030

The medical device affairs outsourcing market is expanding as manufacturers face tougher regulatory demands and growing compliance workloads. The Business Research Company says the market will rise to $7.65 billion by 2030, with Europe currently leading and Asia-Pacific expected to grow fastest.

Why it matters: - Medical device makers are leaning more on outside specialists to manage regulatory and quality tasks as compliance rules get more complex. - The shift matters because outsourcing can speed approvals, support post-market monitoring, and free internal teams to focus on product innovation. - The market’s projected growth signals rising demand for regulatory support services across the global medical device industry.

What happened: - The Business Research Company published its Medical Device Affairs Outsourcing Global Market Report 2026, covering market size, trends and forecasts through 2035. - The report estimates the market will grow from $5.45 billion in 2025 to $5.85 billion in 2026. - The report projects the market will reach $7.65 billion by 2030, implying a 6.9% CAGR over the forecast period. - Europe held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth over the forecast period.

The details: - Medical device affairs outsourcing means contracting external specialists to handle regulatory compliance and quality assurance for medical devices. - The historical growth drivers include tighter regulatory complexity, greater reliance on internal regulatory teams, more medical device approvals, a broader global device market and higher awareness of compliance risk. - Future growth is expected to come from wider use of advanced regulatory software, more outsourcing partnerships, stronger strategic regulatory planning, better post-market surveillance and more artificial intelligence and analytics. - Key trends include increased outsourcing by device makers, higher demand for cloud-based compliance tools, streamlined clinical trial and submission processes, expanded quality management system support and stronger post-market risk assessment. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report says its 2026 edition adds market attractiveness scoring, total addressable market analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics and updated graphics and tables. - A free sample is available here. - The full report is available here.

Between the lines: - Rising device registrations and approvals suggest the compliance burden is increasing alongside product demand. - MHRA reported the number of registered medical products in the UK grew from about 2.25 million in 2022 to around 3.25 million in 2024. - That kind of growth favors outsourced regulatory support because firms need more specialized capacity without adding the same level of permanent headcount. - The growing role of AI, analytics and cloud tools points to a market that is becoming more software-driven as well as service-driven.

What's next: - The market is expected to keep expanding through 2030 as manufacturers increase outsourcing and invest in more efficient compliance systems. - Asia-Pacific’s growth trajectory suggests more regulatory service demand in faster-growing medical device markets. - More emphasis on post-market surveillance and risk assessment should keep quality and compliance services in demand.

The bottom line: - Medical device affairs outsourcing is moving from a back-office support function to a core part of device makers’ global compliance strategy.